Tralokinumab Safe, Effective in Older Pop With AD: Analysis

The findings are important for the older patient population who "typically face unique treatment challenges," the authors write.

Related Keywords

Boston , Massachusetts , United States , Bristol Myers Squibb , Sun Pharma , Josephf Merola , Tralokinumab Adbry , Eli Lilly Incyte , Pfizer , Harvard Medical School , Amgen , European Medicine Agency , Boehringer Ingelheim , Drug Administration , Novartis , Eczema Area , Severity Index , Global Assessment , Eli Lilly , Cosmotique Internacional , Dermatitis , Biologic Therapy , Thromboembolism , Deep Venous Thrombosis Dvt , Deep Vein Thrombosis , Vt Deep Venous Thrombosis , Atopic Dermatitis , Adverse Effects , Side Effects , Clinical Research , Clinical Trials , Linical Studies , Geriatrics Elder Care , Interleukins , Polypharmacy ,